Clinical Trials on Pupillary Occlusion in Austria

Total 470 results

Baker Heart and Diabetes Institute

Recruiting

Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring (EDCAD-PMS)

Coronary Artery Disease

Australia
Boston Scientific Corporation

Completed

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Coronary Artery Disease | Atherosclerosis

Singapore, Australia, New Zealand
Roxane Laboratories

Completed

Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions

Intermittent Claudication

United States
Bayside Health
National Health and Medical Research Council, Australia

Completed

The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial

Coronary Artery Disease

Australia
Roxane Laboratories

Completed

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

Intermittent Claudication

United States
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion (COMINO)

Central Retinal Vein Occlusion | Macular Edema | Hemiretinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Germany, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
C. R. Bard

Completed

Bard® LifeStent® Vascular Stent Delivery System Study

Peripheral Vascular Disease

Austria, Germany
National Institutes of Health Clinical Center (CC)

Completed

Dietary Linoleic Acid for Secondary Prevention of Coronary Heart Disease and Death in the Sydney Heart Study: an RCT

Coronary Heart Disease

Australia
Avinger, Inc.

Completed

Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II (CONNECTII)

Total Atherosclerotic Occlusion of Femoral Artery

United States, Italy, Germany
Austin Health

Active, not recruiting

Radial Artery Patency and Clinical Outcomes Trial (RAPCO)

Coronary Artery Disease | Atherosclerosis

Australia
Abcuro, Inc.
Syneos Health

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Inclusion Body Myositis

United States, Australia, Belgium, France, Canada, Germany, United Kingdom
REVA Medical, Inc.

Recruiting

FANTOM Post Market Clinical Trial

Coronary Artery Disease

Germany, Austria, Switzerland
W.L.Gore & Associates

Recruiting

The GORE® VIAFORT Vascular Stent IVC Study

Venous Leg Ulcer | Venous Stasis | Venous Stenosis | Venous Occlusion | Venous Ulcer | Venous Thromboses | Venous Disease | Vein Thrombosis | Vein Occlusion | Vein Disease

United States, Australia, Germany, Italy, United Kingdom, New Zealand, Ireland
Abbott Medical Devices

Completed

A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System (STRIDES)

Atherosclerosis | Peripheral Vascular Disease

Germany, Austria, Belgium, Italy
Cagent Vascular LLC

Completed

The PRELUDE BTK Study

Peripheral Arterial Disease | Critical Limb Ischemia

New Zealand, Austria, Germany, Poland
Cordis Corporation
FCRE (Foundation for Cardiovascular Research and Education)

Completed

PMCF Study for Peripheral Arteries Above the Knee (ATK)

Peripheral Arterial Disease | Femoropopliteal Stenosis | Angiopathy, Peripheral

Austria, Netherlands, France
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands
R3 Vascular Inc.
Cardiovascular Research Foundation, New York; Massachusetts General Physicians...

Recruiting

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease (RESOLV I)

Peripheral Arterial Disease | Lower Extremity Claudication | Lower Extremity Ischemia | Atherosclerotic Lesion

Canada, Italy, Austria
Cordis Corporation
NAMSA; Qserve

Completed

Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY)

Peripheral Arterial Disease

France, Switzerland, Italy, Austria, Belgium, Spain
Dr Peter Barlis
Biosensors International

Unknown

Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition (OPTIMA)

Coronary Heart Disease

Australia
Bayside Health

Unknown

Investigating the Effects of Hyperoxia on Fractional Flow Reserve

Coronary Artery Disease

Australia
Bayside Health

Completed

Does Rosuvastatin Delay Progression of Atherosclerosis in HIV

Cardiovascular Disease | HIV

Australia, Switzerland
Shockwave Medical, Inc.

Active, not recruiting

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Peripheral Arterial Disease

New Zealand, Australia
University of Melbourne

Unknown

A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function (Intracor)

Myocardial Infarction | Coronary Artery Disease

Australia
Boston Scientific Corporation

Completed

Vortex - Temporary Percutaneous, Transvalvular Circulatory Support System Feasibility Study (Vortex-FIH)

Coronary Artery Disease

Australia, Sweden
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion (BALATON)

Macular Edema | Branch Retinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
Baker Heart and Diabetes Institute

Terminated

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Peripheral Arterial Disease | Intermittent Claudication

Australia
C. R. Bard

Completed

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)

Peripheral Vascular Disease | Venous Disease | May-Thurner Syndrome | Iliofemoral Occlusive Disease

United States, Australia, Germany, Ireland, Netherlands, Spain, United Kingdom
Hemoteq AG
CERES GmbH; coreLab Black Forest GmbH

Completed

Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Claudication

Germany, Austria, France
Abbott Medical Devices

Completed

ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System

Atherosclerosis | Peripheral Vascular Disease | Claudication

Austria, France, Germany, Belgium
Baker Heart and Diabetes Institute
Queen's University, Belfast; University of Melbourne; Heartwest; Western Health

Recruiting

Risk-guided Disease Management in Coronary Artery Disease (Risk-CAD)

Coronary Artery Disease | Chronic Disease | Nurse's Role

Australia
Pierre Fabre Dermatology

Completed

Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Infantile Hemangioma

Germany, United States, France, Spain, Peru, Australia, Lithuania, Italy, Canada, Czech Republic, Hungary, Mexico, New Zealand, Poland, Romania, Russian Federation
Aminex Therapeutics, Inc.

Recruiting

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Melanoma | Cervical Cancer | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Solid Tumor | Endometrial Cancer | Advanced Cancer | Diffuse Midline Glioma, H3 K27M-Mutant | Papillary Thyroid Cancer | Solid Carcinoma | Mesotheliomas Pleural | Glioma, Malignant | Ovary Cancer and other conditions

United States, Australia
Bayer
Regeneron Pharmaceuticals

Completed

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) (GALILEO)

Retinal Vein Occlusion

Italy, Korea, Republic of, France, Germany, Australia, Austria, Singapore, Hungary, Latvia, Japan
Bayer

Terminated

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

PAD | Infrapopliteal Lesions

Belgium, Switzerland, United Kingdom, Austria
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

Recurrent Thyroid Cancer | Recurrent Childhood Rhabdomyosarcoma | Papillary Thyroid Cancer | Recurrent Wilms Tumor and Other Childhood Kidney Tumors | Previously Treated Childhood Rhabdomyosarcoma | Recurrent Childhood Liver Cancer | Childhood Hepatocellular Carcinoma

United States, Canada, Australia
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Ependymoma | Anaplastic Ependymoma | Clear Cell Ependymoma | Brain Ependymoma | Cellular Ependymoma | Papillary Ependymoma

United States, Canada, Australia, New Zealand
FoxHollow Technologies

Terminated

A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease (NightHawk)

Peripheral Vascular Diseases

United States
Monash University
Royal Brompton & Harefield NHS Foundation Trust; IM Medical Ltd, Melbourne

Completed

Alternative Risk Markers in Coronary Artery Disease (ARMCAD)

Coronary Artery Disease

Australia
Abbott Medical Devices

Completed

Observational Study of OCT in a Patients Undergoing FFR (ILUMIEN I)

Coronary Artery Disease

United Kingdom, Japan, United States, France, Canada, Belgium, Australia, Italy, China, Czechia, Austria, Germany, Netherlands, Spain
Biotronik AG

Recruiting

Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular Procedures (BIO-OSCAR SOC)

Peripheral Arterial Disease

Germany, Belgium, Hungary, Austria, France, Italy, Spain, Switzerland
Spectranetics Corporation

Completed

STELLAREX: ILLUMENATE Global and In-Stent Restenosis (ISR) (ILLUMENATE)

Peripheral Arterial Disease

Belgium, Germany, New Zealand, France, United Kingdom, Australia, Poland, Austria, Italy, Spain
Okogen

Active, not recruiting

OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis (RUBY)

Adenoviral Conjunctivitis

Australia
University of Texas at Austin

Completed

Prolonged Sitting on Responses to Short-Term Exercise Training

Atherosclerosis | Metabolic Syndrome

United States
University of Texas at Austin

Completed

The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal

Atherosclerosis | Metabolic Syndrome

United States
University of Texas at Austin

Completed

The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia

Atherosclerosis | Metabolic Syndrome

United States
Bayside Health
Monash University; Baker Heart and Diabetes Institute; Ambulance Victoria; FALCK...

Unknown

Air Verses Oxygen In myocarDial Infarction Study (AVOID)

Coronary Artery Disease | Acute Myocardial Infarction

Australia
Novartis Pharmaceuticals

Completed

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRYSTAL)

Central Retinal Vein Occlusion | Macular Edema

Greece, Hungary, Turkey, Australia, Austria, Netherlands, United Kingdom, Italy, Spain, Ireland, Portugal, Slovakia, Canada, Switzerland, Czech Republic, Poland, Denmark, Sweden
Sanofi

Completed

Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease (ACCELA)

Intermittent Claudication

United States, France, Canada, Poland, Russian Federation, Austria, South Africa

Clinical Trials on Pupillary Occlusion in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations